JP2013505949A5 - - Google Patents

Download PDF

Info

Publication number
JP2013505949A5
JP2013505949A5 JP2012531061A JP2012531061A JP2013505949A5 JP 2013505949 A5 JP2013505949 A5 JP 2013505949A5 JP 2012531061 A JP2012531061 A JP 2012531061A JP 2012531061 A JP2012531061 A JP 2012531061A JP 2013505949 A5 JP2013505949 A5 JP 2013505949A5
Authority
JP
Japan
Prior art keywords
hydroxy
ethoxy
phenyl
nitrophenyl
dihydropyrimidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012531061A
Other languages
English (en)
Japanese (ja)
Other versions
JP5775519B2 (ja
JP2013505949A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/050164 external-priority patent/WO2011038204A1/en
Publication of JP2013505949A publication Critical patent/JP2013505949A/ja
Publication of JP2013505949A5 publication Critical patent/JP2013505949A5/ja
Application granted granted Critical
Publication of JP5775519B2 publication Critical patent/JP5775519B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012531061A 2009-09-25 2010-09-24 S−ニトロソグルタチオンレダクターゼ阻害薬としての新規ジヒドロピリミジン−2(1h)−オン化合物 Expired - Fee Related JP5775519B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24585909P 2009-09-25 2009-09-25
US61/245,859 2009-09-25
PCT/US2010/050164 WO2011038204A1 (en) 2009-09-25 2010-09-24 Novel dihydropyrimidin-2(1h)-one compounds as s-nitrosoglutathione reductase inhibitors

Publications (3)

Publication Number Publication Date
JP2013505949A JP2013505949A (ja) 2013-02-21
JP2013505949A5 true JP2013505949A5 (https=) 2013-11-07
JP5775519B2 JP5775519B2 (ja) 2015-09-09

Family

ID=43796219

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012531061A Expired - Fee Related JP5775519B2 (ja) 2009-09-25 2010-09-24 S−ニトロソグルタチオンレダクターゼ阻害薬としての新規ジヒドロピリミジン−2(1h)−オン化合物

Country Status (4)

Country Link
US (3) US8741915B2 (https=)
EP (1) EP2480086A4 (https=)
JP (1) JP5775519B2 (https=)
WO (1) WO2011038204A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011038204A1 (en) 2009-09-25 2011-03-31 N30 Pharmaceuticals, Llc Novel dihydropyrimidin-2(1h)-one compounds as s-nitrosoglutathione reductase inhibitors
ES2550939T3 (es) 2010-07-16 2015-11-13 Nivalis Therapeutics, Inc. Nuevos compuestos de dihidropiridin-2-(1H)-ona como inhibidores de la S-nitrosoglutatión reductasa y antagonistas del receptor de la neurocinina-3
EP2618666A4 (en) * 2010-09-24 2014-04-16 N30 Pharmaceuticals Inc NEW DIHYDROPYRIMIDIN-2 (1H) -ON COMPOUNDS AS NEUROKININ-3 RECEPTOR ANTAGONISTS
CN104418718B (zh) * 2013-08-28 2018-04-13 山东新时代药业有限公司 一种环丙基‑2‑溴‑2‑(2‑氟苯基)乙酮的制备方法
WO2016055947A1 (en) * 2014-10-07 2016-04-14 Glenmark Pharmaceuticals S.A. Alkyne compounds as s-nitrosoglutathione reductase inhibitors
CN104803954B (zh) * 2015-04-30 2018-01-26 上海应用技术学院 一种福沙那韦中间体的制备方法
WO2018011376A1 (en) * 2016-07-13 2018-01-18 Centre National De La Recherche Scientifique - Cnrs - Pyrimidinone derivatives and uses thereof to neutralize the biological activity of chemokines
WO2018054721A1 (en) 2016-09-26 2018-03-29 Basf Se Pyridine compounds for controlling phytopathogenic harmful fungi
WO2018054723A1 (en) 2016-09-26 2018-03-29 Basf Se Pyridine compounds for controlling phytopathogenic harmful fungi
WO2018054711A1 (en) 2016-09-26 2018-03-29 Basf Se Pyridine compounds for controlling phytopathogenic harmful fungi
WO2018065182A1 (en) 2016-10-04 2018-04-12 Basf Se Reduced quinoline compounds as antifuni agents
WO2018073110A1 (en) 2016-10-20 2018-04-26 Basf Se Quinoline compounds as fungicides
CN121293102A (zh) * 2025-12-10 2026-01-09 寿光富康制药有限公司 一种高纯度2-溴-6-硝基苯甲醛的合成方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US6268369B1 (en) 1994-11-16 2001-07-31 Synaptic Pharmaceutical Corporation 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
KR19990014671A (ko) 1995-05-10 1999-02-25 윌리암스로저에이. 고리형 아미딘으로부터 유도된 산화질소 신타제 저해제
US6057367A (en) 1996-08-30 2000-05-02 Duke University Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses
GB9813271D0 (en) 1998-06-19 1998-08-19 Zeneca Ltd Composition and use
US7049308B2 (en) 2000-10-26 2006-05-23 Duke University C-nitroso compounds and use thereof
US6359182B1 (en) 2000-10-26 2002-03-19 Duke University C-nitroso compounds and use thereof
US7179791B2 (en) 2001-01-11 2007-02-20 Duke University Inhibiting GS-FDH to modulate NO bioactivity
US7317014B2 (en) 2002-07-22 2008-01-08 Orchid Research Laboratories, Ltd. Bio-active pyrimidine molecules
GB0220961D0 (en) * 2002-09-10 2002-10-23 Bayer Ag Heterocyclic derivatives
US7566723B2 (en) 2002-09-10 2009-07-28 Bayer Healthcare Ag 1-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use
CA2524882A1 (en) 2003-05-06 2004-11-25 Cytovia, Inc. Protease inhibitors for coronaviruses and sars-cov and the use thereof
WO2005000229A2 (en) 2003-06-04 2005-01-06 Duke University Compositions and methods for modulating s-nitrosoglutathione reductase
WO2005054239A1 (en) * 2003-12-05 2005-06-16 Bayer Healthcare Ag 2-aminopyrimidine derivatives
FR2883284A1 (fr) 2005-03-15 2006-09-22 Commissariat Energie Atomique Nouveaux derives dihydropyrimidines et leur utilisation comme agents anti-cancereux
EP1731911A1 (fr) 2005-06-07 2006-12-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Procédé utile pour la détection d'encéphalopathies
JP4488963B2 (ja) 2005-06-23 2010-06-23 株式会社Adeka 光学記録材料
WO2007101213A2 (en) * 2006-02-28 2007-09-07 Kalypsys, Inc. Novel 2-oxo-1,2,3,4-tetrahydropyrimidines, bicyclic pyrimidine diones and imidazolidine-2,4-diones useful as inducible nitric oxide synthase inhibitors
US8034822B2 (en) 2006-03-08 2011-10-11 Takeda San Diego, Inc. Glucokinase activators
RU2329260C1 (ru) 2007-02-20 2008-07-20 Юрий Иосифович Копырин Способ получения 2-анилинопиримидинов или их солей (варианты)
AU2008232354B9 (en) 2007-03-27 2012-07-26 Synta Pharmaceuticals Corp. Triazinone and diazinone derivatives useful as Hsp90 inhibitors
WO2009019800A1 (ja) 2007-08-06 2009-02-12 Nagoya Industrial Science Research Institute 濾過装置及び濾過方法
WO2009076665A1 (en) * 2007-12-13 2009-06-18 Indiana University Research And Technology Corporation Materials and methods for inhibiting mammalian s-nitrosoglutathione reductase
CA2709784A1 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
WO2009150668A1 (en) 2008-06-13 2009-12-17 Delhi University Dihydropyridimidinone compounds for the treatment of cardiovascular diseases and process for preparing the same
DK2318007T3 (da) * 2008-08-15 2013-03-25 N30 Pharmaceuticals Inc Nye pyrrol-inhibitorer af s-nitrosoglutathion-reduktase som terapeutiske midler
WO2010046780A2 (en) 2008-10-22 2010-04-29 Institut Pasteur Korea Anti viral compounds
WO2010107476A1 (en) 2009-03-19 2010-09-23 Duke University Inhibiting gsnor
WO2011038204A1 (en) 2009-09-25 2011-03-31 N30 Pharmaceuticals, Llc Novel dihydropyrimidin-2(1h)-one compounds as s-nitrosoglutathione reductase inhibitors
ES2550939T3 (es) 2010-07-16 2015-11-13 Nivalis Therapeutics, Inc. Nuevos compuestos de dihidropiridin-2-(1H)-ona como inhibidores de la S-nitrosoglutatión reductasa y antagonistas del receptor de la neurocinina-3
EP2618666A4 (en) * 2010-09-24 2014-04-16 N30 Pharmaceuticals Inc NEW DIHYDROPYRIMIDIN-2 (1H) -ON COMPOUNDS AS NEUROKININ-3 RECEPTOR ANTAGONISTS

Similar Documents

Publication Publication Date Title
JP2013505949A5 (https=)
JP2008516946A5 (https=)
JP6862033B2 (ja) Gpr120アゴニストとしてのビアリール誘導体
AU738037B2 (en) Nicotinamide derivatives
US9938236B2 (en) Antiviral agents against HBV infection
EP0733033B1 (en) Pharmaceutically active substituted aromatic compounds
RU2487713C2 (ru) Фармацевтическая композиция и способ лечения или профилактики физиологических и/или патофизиологических состояний, ассоциированных с ингибированием киназ pi3k, у млекопитающих
JP2011517458A5 (https=)
JP2010539187A5 (https=)
JP5494482B2 (ja) トリアゾール誘導体またはその塩
JP2013542937A5 (https=)
CN110642741A (zh) 作为抗hbv感染的抗病毒剂的官能化苯甲酰胺衍生物
JP2012526803A5 (https=)
HRP20151201T1 (hr) Supstituirani derivati benzamida
JP2010540462A5 (https=)
JP2006509748A5 (https=)
KR102905375B1 (ko) Rna 바이러스 감염을 치료하기 위한 페닐/피리딜-n-페닐/피리딜 유도체
JP2007514003A6 (ja) アデノシン受容体アンタゴニストとしての2,6−ビスヘテロアリール−4−アミノピリミジン
MXPA06006776A (es) 2,6-bisheteroaril-4-aminopirimidinas como antagonistas del receptor de adenosina.
RU2008136553A (ru) Производные бензотиазола в качестве агонистов бета2 адренорецептора
JP2005523901A (ja) Npyアンタゴニストとしてのキノリン誘導体
JP2006503081A5 (https=)
JP2013519724A5 (https=)
HRP20160359T1 (hr) Derivati kinazolindiona, njihovo dobivanje i njihove terapijske primjene
JP2009520021A5 (https=)